| Zugriffe | |
|---|---|
| Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis | 287 |
| Juni 2024 | Juli 2024 | August 2024 | September 2024 | Oktober 2024 | November 2024 | Dezember 2024 | |
|---|---|---|---|---|---|---|---|
| Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis | 4 | 3 | 6 | 5 | 2 | 5 | 0 |
| Zugriffe | |
|---|---|
| 1065.full.pdf | 157 |
